logo
Research sheds light on bacteria outbreak that killed 1 person, several ABQ BioPark Zoo primates

Research sheds light on bacteria outbreak that killed 1 person, several ABQ BioPark Zoo primates

Yahoo2 days ago
ALBUQUERQUE, N.M. (KRQE) – A bacterial outbreak in Albuquerque between May 2021 and November 2023 that spread among people and primates from the ABQ BioPark Zoo, came from the same source, according to newly published research.
The illness that plagued the community was determined to be shigella, a highly contagious gastrointestinal infection that is spread through the fecal-oral route and can be contracted by drinking contaminated food or water or coming into contact with someone who is sick or recently infected with shigellosis.
Story continues below
Education: APS Board members respond after vulgar text messages sent during board meeting
New Mexico News Insiders: PFAS: The Most Contaminated Waters In New Mexico
Trending: Albuquerque officials discuss moving historic diner to Route 66 Visitor Center
The shigella outbreak left one person dead, and nearly 70% of people with the infection were hospitalized, according to the research article. The infection spread into the zoo, resulting in the death of six primates and leaving others infected.
Upon learning of the outbreak, BioPark and NMDOH staff worked together to address the spread among both populations. Researchers were able to learn more about the outbreak, how it spread, and where it may have come from.
The research team started by analyzing gene sequence samples from infected humans and primates.
'In looking at the genomes between human cases and the primate cases, we were able to see that in that there were zero differences. So there is no way that happens by chance. That means that they were the same strain of Shigella that was circulating in the zoo and in the human population,' said Sarah Shrum Davis, emerging infections program foodnet coordinator for the UNM Office of Community Health, and an NMDOH enteric team lead.
Based on the data, Shrum Davis, and researchers were able to conclude the Shigella outbreak came from the same source, was introduced around February 2021, and possibly came from Texas. '
'So bacteria evolve at a certain rate, and so Shigella evolves at a rate of about three mutations per year. We were able to look at the genetic sequences of our Shigella bacteria, and the closest strain that matched them did occur in Texas. And so by doing it by looking at the evolutionary rate of the bacteria, this is called a molecular clock, we were able to backtrace about when we think it was introduced into New Mexico,' she explained.
According to Shrum Davis, cases of Shigella are reported year-round across the state of New Mexico. But what caught health officials' attention was the sharp uptick in cases in the Albuquerque area in both humans and primates around May 2021.
NMDOH began investigating and alerted doctors that the strain was resistant to the first line of antibiotics that are used for treatment, and that they should potentially try and use other drugs to treat patients in this area. The City of Albuquerque also set up portable hand-washing stations to prevent the spread, Shrum Davis said.
As for the ABQ BioPark, it had temporarily closed the Ape Walk while it provided medicine and care to its primates, including orangutans, siamangs, and gorillas.
Unfortunately, some of the treatments did not work. 'I was disappointed and heartbroken when some of our animals were not getting better as quickly as I had hoped,' Carol Bradford, the senior veterinarian at the ABQ BioPark Zoo, said in an interview with UNM Health Sciences. 'Even though they were treated with appropriate antibiotics, the antibiotics didn't seem to make them feel better very quickly.'
Bradford said there were 13 animals that were affected by the illness over the course of several weeks. 'What we do not think happened, and we want to be really clear about this, is that we don't think that there is any intentional exposure, and we don't think that, you know, anybody sort of had like contact with animals that they shouldn't have or anything like that. No keepers were sick,' said Shrum Davis.
Researchers still do not know how the bacteria spread to the primates, but they do have a guess.
'Our leading hypotheses are that, you know, somebody who, you know, had the Shigella bacteria on their hands threw something into the primate areas and contaminated that way. We also do wonder about the potential of things like house flies bringing it in. Although the zoo does trap for flies, you know, at a certain point, there's only so much you can do,' Shrum Davis explained.
The ABQ BioPark Zoo does have signs warning visitors not to throw food or other items into enclosures.
To view the published research article, click here.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UnitedHealth Group (UNH) Responds to the Department of Justice
UnitedHealth Group (UNH) Responds to the Department of Justice

Yahoo

time5 minutes ago

  • Yahoo

UnitedHealth Group (UNH) Responds to the Department of Justice

UnitedHealth Group Incorporated (NYSE:UNH) is one of the top low volatility healthcare stocks to buy now. On July 24, UnitedHealth Group Incorporated (NYSE:UNH) released a statement responding to the Department of Justice after a review of the media reports about investigations into specific aspects of its involvement in the Medicare program. A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group Incorporated (NYSE:UNH) stated that it has now begun complying with the formal criminal and civil requests from the Department, and has 'full confidence in its practices and is committed to working cooperatively with the Department throughout this process'. It added that UnitedHealth Group Incorporated (NYSE:UNH) has a historical record of 'responsible conduct and effective compliance,' with independent CMS audits showing that its practices are ranked 'among the most accurate in the industry.' Management stated that after a decade-long civil challenge by the Department to aspects of the company's Medicare Advantage business, 'a court-appointed Special Master concluded there was no evidence to support claims of wrongdoing'. UnitedHealth Group Incorporated (NYSE:UNH) has launched its own initiative to provide confidence and transparency to stakeholders, focusing on conducting 'third-party reviews of policies, practices, and associated processes and performance metrics for risk assessment coding, managed care practices, and pharmacy services.' UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments, which have solid operations. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

Patients With Acromegaly Face Higher Cancer Risk
Patients With Acromegaly Face Higher Cancer Risk

Medscape

time7 minutes ago

  • Medscape

Patients With Acromegaly Face Higher Cancer Risk

TOPLINE: Patients with acromegaly had significantly higher odds of developing leukemia/lymphoma or ovarian, breast, lung, or other cancers, many of which occurred at younger ages than typically seen in the general population. These data underscored the urgent need to integrate cancer screening protocols into routine care for patients with acromegaly to facilitate earlier detection and intervention. METHODOLOGY: Excess growth hormone secretion in patients with acromegaly increases the levels of insulin-like growth factor, a known cancer risk factor; however, the true prevalence of cancer in these patients is not well known. Researchers conducted a retrospective cohort analysis using data from a multinational research network platform to compare cancer prevalence in individuals with acromegaly and those without the condition. Patients with acromegaly (n = 10,207; mean age at disease onset, 43.2 years; 52.9% women) were matched with 102,070 individuals from the general population without the condition. TAKEAWAY: Patients with acromegaly had a 3.3-fold increased odds of developing leukemia/lymphoma (95% CI, 2.3-4.67), a 1.9-fold increased odds of developing ovarian cancer (95% CI, 1.3-2.8), a 1.8-fold increased odds of developing breast cancer (95% CI, 1.5-2.0), 1.9-fold increased odds of developing lung cancer (95% CI, 1.5-2.3), and a 1.5-fold increased odds of developing prostate cancer (95% CI, 1.3-1.8). The onset of certain cancers, specifically ovarian, lung, liver, and neuroendocrine, occurred much earlier (3.2-7.2 years) in patients with acromegaly than in control individuals from the general population. IN PRACTICE: 'Our findings suggest that acromegaly may play a bigger role in cancer risk than previously thought, highlighting the need for increased awareness and early cancer screening in this population,' said the lead researcher in a press release. SOURCE: This study was led by Hitam Hagog Natour, MD, Thomas Jefferson University Hospital in Philadelphia. It was presented on July 14, 2025, at the ENDO 2025: The Endocrine Society Annual Meeting in San Francisco. LIMITATIONS: This study did not report any specific limitations. DISCLOSURES: This study did not report any specific funding or conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Cancer Care Costs High Among Privately Insured Patients
Cancer Care Costs High Among Privately Insured Patients

Medscape

time7 minutes ago

  • Medscape

Cancer Care Costs High Among Privately Insured Patients

TOPLINE: A recent analysis found that privately insured US patients with newly diagnosed cancer, especially those with more advanced disease, had 'substantial out-of-pocket costs.' Monthly out-of-pocket costs among these patients increased by a mean of almost $600, on average, but increased to nearly $720 per month for those with stage IV disease. METHODOLOGY: Out-of-pocket costs for cancer care in the US are rising, but most research has focused on Medicare beneficiaries. It's important to understand privately insured patients' financial burdens, especially with cancer rates growing among younger Americans. Researchers conducted a retrospective study of 19,656 patients with cancer, using a dataset that links claims from a large private insurer to the Surveillance, Epidemiology, and End Results cancer registry. Overall, 74.1% had breast cancer, 14.5% had colorectal cancer, and 11.4% had lung cancer. Analyses also included 26,502 individuals without cancer who were assigned pseudo – diagnosis date. Monthly out-of-pocket costs (copays, co-insurance, and deductibles) were calculated from claims and inflation-adjusted to 2024 US dollars. TAKEAWAY: After a cancer diagnosis, monthly out-of-pocket costs rose by $592, on average. Those added costs increased with disease stage, from $462 per month for stage 0 cancer to $720 per month for stage IV cancer. Out-of-pocket costs spiked in the month of diagnosis and remained elevated for 6 months compared with those in individuals without cancer — totaling an average of $4145 in cumulative additional costs (over 7 months). IN PRACTICE: 'In this cohort study, patients with private insurance were found to have high OOPCs [out-of-pocket costs] after an incident diagnosis of cancer, and those with the most advanced cancer had the highest OOPCs,' the authors wrote. 'The variability in OOPCs based on cancer stage underscores the need for policies such as paid sick leave, that address both insurance continuity and financial assistance, especially for patients with more advanced cancer.' SOURCE: This study, led by Liam Rose, PhD, Stanford University School of Medicine, Palo Alto, California, was published online in JAMA Network Open. LIMITATIONS: Differential insurance attrition could have affected the results: Patients with stage IV cancer were most likely to drop their coverage. The study could only capture direct medical costs, which misses other potential financial burdens, such as lost income and travel expenses. DISCLOSURES: This study received funding support through a grant from the American Cancer Society. One author reported receiving grants from the Department of Veterans Affairs and National Institutes of Health during the conduct of the study. No other disclosures were reported. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store